Scholar Rock Holding EPS - Earnings per Share 2017-2019 | SRRK

Scholar Rock Holding eps - earnings per share from 2017 to 2019. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Scholar Rock Holding Annual EPS
2018 $-3.15
2017 $-15.30
2016 $-10.11
Scholar Rock Holding Quarterly EPS
Q1 2019 $-0.42
Q4 2018 $1.86
Q3 2018 $-0.44
Q2 2018 $-1.39
Q1 2018 $-3.18
Q4 2017 $0.00
Q3 2017 $-0.00
Q2 2017 $-3.67
Q4 2016 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.374B $0.000B
Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.303B 13.93
Gilead Sciences (GILD) United States $81.218B 9.97
Celgene (CELG) United States $67.812B 10.49
Vertex Pharmaceuticals (VRTX) United States $47.911B 51.78
Biogen (BIIB) United States $43.009B 7.64
Illumina (ILMN) United States $42.704B 50.17
CSL (CSLLY) Australia $36.183B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.705B 14.84
Alexion Pharmaceuticals (ALXN) United States $25.750B 13.57
Incyte (INCY) United States $18.511B 54.47
Exact Sciences (EXAS) United States $15.439B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.038B 0.00
Seattle Genetics (SGEN) United States $12.933B 0.00
Genmab (GNMSF) Denmark $12.462B 70.36
Bio-Rad Laboratories (BIO.B) United States $9.886B 52.99
Guardant Health (GH) United States $9.702B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.271B 0.00
Galapagos (GLPG) Belgium $8.686B 0.00
QIAGEN (QGEN) Netherlands $7.848B 25.78
Sarepta Therapeutics (SRPT) United States $7.546B 0.00
Bio-Techne Corp (TECH) United States $7.317B 50.58
BeiGene (BGNE) Cayman Islands $6.934B 0.00
Bluebird Bio (BLUE) United States $6.539B 0.00
Exelixis (EXEL) United States $6.512B 16.93
Amarin (AMRN) Ireland $5.733B 0.00
Horizon Pharma Public (HZNP) Ireland $5.215B 13.26
Ascendis Pharma (ASND) Denmark $4.896B 0.00
Repligen (RGEN) United States $4.812B 93.38
Moderna (MRNA) United States $4.718B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.460B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.310B 0.00
MorphoSys AG (MOR) Germany $3.964B 0.00
Blueprint Medicines (BPMC) United States $3.904B 0.00
China Biologic Products (CBPO) China $3.903B 24.37
Spark Therapeutics (ONCE) United States $3.898B 0.00
Mirati Therapeutics (MRTX) United States $3.613B 0.00
Alkermes (ALKS) Ireland $3.495B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.389B 0.00
Arena Pharmaceuticals (ARNA) United States $2.840B 6.10
Genomic Health (GHDX) United States $2.772B 51.99
NeoGenomics (NEO) United States $2.725B 145.78
Medicines (MDCO) United States $2.722B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.677B 0.00
Immunomedics (IMMU) United States $2.674B 0.00
Amicus Therapeutics (FOLD) United States $2.618B 0.00
MyoKardia (MYOK) United States $2.570B 0.00
Acceleron Pharma (XLRN) United States $2.494B 0.00
Halozyme Therapeutics (HALO) United States $2.454B 0.00
Reata Pharmaceuticals (RETA) United States $2.261B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.206B 0.00
Emergent Biosolutions (EBS) United States $2.172B 32.64
UniQure (QURE) Netherlands $2.137B 0.00
Zai Lab (ZLAB) China $2.071B 0.00
Akcea Therapeutics (AKCA) United States $2.052B 0.00
Cambrex (CBM) United States $1.994B 25.20
Myriad Genetics (MYGN) United States $1.853B 19.45
Ligand Pharmaceuticals (LGND) United States $1.853B 23.43
Denali Therapeutics (DNLI) United States $1.780B 0.00
Coherus BioSciences (CHRS) United States $1.529B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.504B 0.00
Insmed (INSM) United States $1.472B 0.00
RA PHARMCTL INC (RARX) United States $1.405B 0.00
REGENXBIO (RGNX) United States $1.354B 0.00
Sangamo Therapeutics (SGMO) United States $1.331B 0.00
Editas Medicine (EDIT) United States $1.281B 0.00
Fate Therapeutics (FATE) United States $1.261B 0.00
Epizyme (EPZM) United States $1.236B 0.00
Athenex (ATNX) United States $1.217B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.215B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.209B 0.00
Innoviva (INVA) United States $1.172B 3.38
AnaptysBio (ANAB) United States $1.171B 0.00
Alector (ALEC) United States $1.090B 0.00
Twist Bioscience (TWST) United States $0.999B 0.00
Zymeworks (ZYME) Canada $0.999B 0.00
Cara Therapeutics (CARA) United States $0.964B 0.00
Principia Biopharma (PRNB) United States $0.954B 497.38
Dicerna Pharmaceuticals (DRNA) United States $0.927B 0.00
Intellia Therapeutics (NTLA) United States $0.836B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.834B 0.00
Cytokineticsorporated (CYTK) United States $0.818B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.816B 0.00
ANI Pharmaceuticals (ANIP) United States $0.811B 13.55
Arvinas (ARVN) United States $0.809B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.802B 28.96
Anika Therapeutics (ANIK) United States $0.785B 27.80
Alder BioPharmaceuticals (ALDR) United States $0.785B 0.00
Codexis (CDXS) United States $0.769B 0.00
Vericel (VCEL) United States $0.767B 0.00
Adverum Biotechnologies (ADVM) United States $0.764B 0.00
Pharming Group (PHGUF) Netherlands $0.759B 0.00
WAVE Life Sciences (WVE) Singapore $0.755B 0.00
Retrophin (RTRX) United States $0.747B 0.00
Zealand Pharma (ZLDPF) Denmark $0.664B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.662B 0.00
Zealand Pharma (ZEAL) Denmark $0.647B 7.51
MiMedx (MDXG) United States $0.618B 0.00
Stemline Therapeutics (STML) United States $0.603B 0.00
Heska (HSKA) United States $0.586B 75.90
DBV Technologies S.A (DBVT) France $0.569B 0.00
Cellectis S.A (CLLS) France $0.531B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.517B 0.00
PHARMA MAR SA (PHMMF) Spain $0.508B 0.00
Revance Therapeutics (RVNC) United States $0.495B 0.00
Intra-Cellular Therapies (ITCI) United States $0.491B 0.00
Precision BioSciences (DTIL) United States $0.472B 0.00
Syros Pharmaceuticals (SYRS) United States $0.466B 0.00
Mesoblast (MESO) Australia $0.461B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.448B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.439B 0.00
CytomX Therapeutics (CTMX) United States $0.429B 0.00
Puma Biotechnology (PBYI) United States $0.426B 0.00
Merus (MRUS) Netherlands $0.410B 0.00
Agenus (AGEN) United States $0.405B 0.00
BioDelivery Sciences (BDSI) United States $0.398B 0.00
Avid Bioservices (CDMO) United States $0.397B 0.00
Gritstone Oncology (GRTS) United States $0.385B 0.00
AC Immune SA (ACIU) Switzerland $0.381B 28.20
AMAG Pharmaceuticals (AMAG) United States $0.361B 0.00
Kadmon Holdings (KDMN) United States $0.340B 0.00
Albireo Pharma (ALBO) United States $0.335B 0.00
Clovis Oncology (CLVS) United States $0.331B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Arcus Biosciences (RCUS) United States $0.320B 0.00
Theratechnologies (THERF) Canada $0.319B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Protagonist Therapeutics (PTGX) United States $0.311B 0.00
Kindred Biosciences (KIN) United States $0.305B 0.00
Sorrento Therapeutics (SRNE) United States $0.303B 0.00
Prothena (PRTA) Ireland $0.301B 0.00
PDL BioPharma (PDLI) United States $0.297B 7.65
Dynavax Technologies (DVAX) United States $0.294B 0.00
Cel-Sci (CVM) United States $0.293B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.272B 0.00
Geron (GERN) United States $0.268B 0.00
Seres Therapeutics (MCRB) United States $0.259B 0.00
Senesco Technologies (ELOX) United States $0.248B 0.00
PHASEBIO PHARMA (PHAS) United States $0.247B 0.00
ADMA Biologics Inc (ADMA) United States $0.241B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.238B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.236B 0.00
Inovio Pharmaceuticals (INO) United States $0.234B 0.00
Cellular Biomedicine (CBMG) United States $0.233B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.232B 0.00
ChromaDex (CDXC) United States $0.223B 0.00
Pfenex (PFNX) United States $0.220B 0.00
Kamada (KMDA) Israel $0.217B 8.31
Athersys (ATHX) United States $0.214B 0.00
Five Prime Therapeutics (FPRX) United States $0.213B 0.00
MannKind (MNKD) United States $0.212B 0.00
Compugen (CGEN) Israel $0.204B 0.00
Palatin Technologies (PTN) United States $0.196B 0.00
CorMedix Inc (CRMD) United States $0.195B 0.00
Sutro Biopharma (STRO) United States $0.193B 0.00
Prometic Life Sciences (PFSCF) Canada $0.189B 0.00
Cue Biopharma (CUE) United States $0.185B 0.00
Spero Therapeutics (SPRO) United States $0.185B 0.00
Affimed (AFMD) Germany $0.175B 0.00
Dyadic (DYAI) United States $0.174B 0.00
Cerecor (CERC) United States $0.169B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.165B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Novavax (NVAX) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) $0.163B 0.00
Emmaus Life Sciences (EMMA) United States $0.160B 0.00
Arsanis (XFOR) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.156B 0.00
XOMA (XOMA) United States $0.155B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.153B 0.00
OSMOTICA PHARM (OSMT) United States $0.153B 0.00
Acorda Therapeutics (ACOR) United States $0.151B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.150B 0.00
Alcobra (ARCT) United States $0.147B 0.00
Nicox SA (NICXF) France $0.147B 0.00
BioTime (LCTX) United States $0.144B 9.60
Strongbridge Biopharma (SBBP) United States $0.141B 5.78
Adocia (ADOCY) France $0.140B 0.00
Windtree Therapeutics (WINT) United States $0.133B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.132B 0.00
NantKwest (NK) United States $0.132B 0.00
Mersana Therapeutics (MRSN) United States $0.131B 0.00
Celyad SA (CYAD) Belgium $0.128B 0.00
Fortress Biotech (FBIO) United States $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.124B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.119B 0.00
Northwest Biotherapeutics (NWBO) United States $0.116B 0.00
TOCAGEN INC (TOCA) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.114B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.112B 0.00
Menlo Therapeutics (MNLO) United States $0.109B 0.00
Abeona Therapeutics (ABEO) United States $0.109B 0.00
Aduro Biotech (ADRO) United States $0.108B 0.00
Aptinyx (APTX) United States $0.106B 0.00
Liquidia Technologies (LQDA) United States $0.104B 0.00
Verastem (VSTM) United States $0.103B 0.00
Synlogic (SYBX) United States $0.102B 0.00
OvaScience (MLND) United States $0.097B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.095B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.088B 0.00
Catalyst Biosciences (CBIO) United States $0.087B 0.00
Trevena (TRVN) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.081B 0.00
Selecta Biosciences (SELB) United States $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.080B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.079B 0.00
Vaccinex (VCNX) United States $0.077B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.072B 0.00
ARAVIVE, INC (ARAV) United States $0.069B 0.00
AquaBounty Technologies (AQB) United States $0.067B 0.00
Curis (CRIS) United States $0.067B 0.00
Idera Pharmaceuticals (IDRA) United States $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.066B 0.00
Unum Therapeutics (UMRX) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.062B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
VBI Vaccines (VBIV) United States $0.060B 0.00
Prima BioMed (IMMP) Australia $0.055B 0.00
Applied Genetic Technologies (AGTC) United States $0.055B 30.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
AIT Therapeutics (XAIR) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.052B 0.00
Ophthotech (ISEE) United States $0.048B 0.00
Clearside Biomedical (CLSD) United States $0.048B 0.00
VIVUS (VVUS) United States $0.042B 0.00
Signal Genetics (MGEN) United States $0.042B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Celsion (CLSN) United States $0.041B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.037B 0.00
Proteostasis Therapeutics (PTI) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
AEterna Zentaris (AEZS) United States $0.034B 0.00
Entera Bio (ENTX) Israel $0.034B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
VistaGen Therapeutics (VTGN) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Vical (VICL) United States $0.020B 0.00
Bionano Genomics (BNGO) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.27
CollPlant Holdings (CLGN) Israel $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
IBio (IBIO) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Novelion Therapeutics (NVLN) Canada $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
AmpliPhi Biosciences (ARMP) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
IMMURON (IMRN) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Hemispherx BioPharma (HEB) United States $0.005B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
Neuralstem (CUR) United States $0.002B 0.00